August 20, 2024

Blinatumomab improves 3-year overall survival in B-ALL versus chemotherapy (study E1910)

August 17, 2024

Nivolumab’s role in esophageal cancer neoadjuvant therapy: Dr. Jennifer Eads (study EA2174)

August 1, 2024

Advocate Health Care and Aurora Health Care cancer clinics join the EAQ211 trial, which seeks to determine why young lymphoma survivors are at high risk for other health problems

July 9, 2024

ECOG-ACRIN research advocate and prostate cancer survivor Brian Jones is profiled in Cancer Today

July 2, 2024

The Summer 2024 advocacy blog, Considering Clinical Trials, is now available

June 18, 2024

Dr. Barbara Burtness and colleagues highlight progress in head and neck cancer MRD at ASCO, but caution that results remain preliminary (free registration is required to view this article)

June 14, 2024

E1910 trial leads to an FDA approval in B-cell acute lymphoblastic leukemia (B-ALL)

June 13, 2024

Nivolumab fails to benefit esophageal cancer treatment in the EA2174 trial: Dr. Jennifer Eads

June 13, 2024

Dr. Jennifer Eads on nivolumab plus neoadjuvant chemoradiation in esophageal/GEJ cancer (trial EA2174)

ECOG-ACRIN Cancer Research Group